Annual Working Capital
$10.68 B
-$352.11 M-3.19%
December 1, 2023
Summary
- As of February 8, 2025, SVA annual working capital is $10.68 billion, with the most recent change of -$352.11 million (-3.19%) on December 1, 2023.
- During the last 3 years, SVA annual working capital has risen by +$9.80 billion (+1113.00%).
- SVA annual working capital is now -14.55% below its all-time high of $12.50 billion, reached on December 31, 2021.
Performance
SVA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$10.17 B
-$512.82 M-4.80%
June 1, 2024
Summary
- As of February 8, 2025, SVA quarterly working capital is $10.17 billion, with the most recent change of -$512.82 million (-4.80%) on June 1, 2024.
- Over the past year, SVA quarterly working capital has dropped by -$409.57 million (-3.87%).
- SVA quarterly working capital is now -18.97% below its all-time high of $12.55 billion, reached on June 30, 2022.
Performance
SVA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SVA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.2% | -3.9% |
| 3 y3 years | +1113.0% | +21.3% |
| 5 y5 years | +4627.5% | +3775.6% |
SVA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.6% | at low | -19.0% | at low |
| 5 y | 5-year | -14.6% | +3971.0% | -19.0% | +4430.2% |
| alltime | all time | -14.6% | >+9999.0% | -19.0% | >+9999.0% |
Sinovac Biotech Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.17 B(-4.8%) |
| Dec 2023 | $10.68 B(-3.2%) | $10.68 B(+1.0%) |
| Jun 2023 | - | $10.58 B(-4.1%) |
| Dec 2022 | $11.03 B(-11.7%) | $11.03 B(-12.1%) |
| Jun 2022 | - | $12.55 B(+0.4%) |
| Dec 2021 | $12.50 B(+1319.6%) | $12.50 B(+49.2%) |
| Jun 2021 | - | $8.38 B(+851.7%) |
| Dec 2020 | $880.68 M(+235.6%) | $880.68 M(+281.4%) |
| Sep 2020 | - | $230.91 M(+2.9%) |
| Jun 2020 | - | $224.49 M(-9.5%) |
| Mar 2020 | - | $248.06 M(-5.5%) |
| Dec 2019 | $262.41 M(+16.1%) | $262.41 M(+9.8%) |
| Sep 2019 | - | $239.09 M(+2.2%) |
| Jun 2019 | - | $233.97 M(+3.2%) |
| Mar 2019 | - | $226.67 M(+0.3%) |
| Dec 2018 | $225.97 M(+102.9%) | $225.97 M(+74.8%) |
| Jun 2018 | - | $129.26 M(+16.1%) |
| Dec 2017 | $111.34 M(+72.7%) | $111.34 M(+31.7%) |
| Jun 2017 | - | $84.54 M(+31.1%) |
| Dec 2016 | $64.48 M(-8.3%) | $64.48 M(+7.5%) |
| Sep 2016 | - | $59.96 M(+6.7%) |
| Jun 2016 | - | $56.21 M(-19.7%) |
| Mar 2016 | - | $70.04 M(-0.5%) |
| Dec 2015 | $70.36 M(-6.2%) | $70.36 M(-4.2%) |
| Sep 2015 | - | $73.47 M(-1.5%) |
| Jun 2015 | - | $74.60 M(+6.1%) |
| Mar 2015 | - | $70.34 M(-6.2%) |
| Dec 2014 | $74.97 M(-30.6%) | $74.97 M(-12.5%) |
| Sep 2014 | - | $85.63 M(+3.4%) |
| Jun 2014 | - | $82.83 M(-11.3%) |
| Mar 2014 | - | $93.42 M(-13.6%) |
| Dec 2013 | $108.09 M(+12.4%) | $108.09 M(+14.6%) |
| Sep 2013 | - | $94.31 M(-12.2%) |
| Jun 2013 | - | $107.39 M(+7.4%) |
| Mar 2013 | - | $100.01 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $96.13 M(+3.9%) | $96.13 M(+17.9%) |
| Sep 2012 | - | $81.53 M(-5.3%) |
| Jun 2012 | - | $86.06 M(-3.1%) |
| Mar 2012 | - | $88.78 M(-4.0%) |
| Dec 2011 | $92.51 M(-8.9%) | $92.51 M(-2.6%) |
| Sep 2011 | - | $95.00 M(-1.1%) |
| Jun 2011 | - | $96.04 M(+4.9%) |
| Mar 2011 | - | $91.51 M(-9.9%) |
| Dec 2010 | $101.54 M(+48.7%) | $101.54 M(-19.6%) |
| Sep 2010 | - | $126.36 M(-2.3%) |
| Jun 2010 | - | $129.33 M(+1.0%) |
| Mar 2010 | - | $127.99 M(+87.4%) |
| Dec 2009 | $68.30 M(+66.6%) | $68.30 M(+19.0%) |
| Sep 2009 | - | $57.41 M(+5.9%) |
| Jun 2009 | - | $54.22 M(+41.8%) |
| Mar 2009 | - | $38.23 M(-6.8%) |
| Dec 2008 | $41.00 M(+118.8%) | $41.00 M(+7.0%) |
| Sep 2008 | - | $38.33 M(+10.0%) |
| Jun 2008 | - | $34.84 M(+18.0%) |
| Mar 2008 | - | $29.54 M(+57.6%) |
| Dec 2007 | $18.74 M(+89.7%) | $18.74 M(+24.4%) |
| Sep 2007 | - | $15.06 M(-8.0%) |
| Jun 2007 | - | $16.37 M(+65.8%) |
| Dec 2006 | $9.88 M(+32.9%) | $9.88 M(+28.9%) |
| Jun 2006 | - | $7.66 M(+3.1%) |
| Dec 2005 | $7.43 M(+309.5%) | $7.43 M(+467.0%) |
| Jun 2005 | - | $1.31 M(-27.8%) |
| Dec 2004 | $1.81 M(+232.4%) | $1.81 M(-2.0%) |
| Sep 2004 | - | $1.85 M(-49.0%) |
| Jun 2004 | - | $3.63 M(+565.1%) |
| Dec 2003 | $545.90 K(+1744.3%) | $545.90 K |
| Apr 2002 | $29.60 K(-104.9%) | - |
| Apr 2001 | -$607.90 K(-924.8%) | - |
| Apr 2000 | $73.70 K(+154.1%) | - |
| Apr 1999 | $29.00 K | - |
FAQ
- What is Sinovac Biotech annual working capital?
- What is the all time high annual working capital for Sinovac Biotech?
- What is Sinovac Biotech annual working capital year-on-year change?
- What is Sinovac Biotech quarterly working capital?
- What is the all time high quarterly working capital for Sinovac Biotech?
- What is Sinovac Biotech quarterly working capital year-on-year change?
What is Sinovac Biotech annual working capital?
The current annual working capital of SVA is $10.68 B
What is the all time high annual working capital for Sinovac Biotech?
Sinovac Biotech all-time high annual working capital is $12.50 B
What is Sinovac Biotech annual working capital year-on-year change?
Over the past year, SVA annual working capital has changed by -$352.11 M (-3.19%)
What is Sinovac Biotech quarterly working capital?
The current quarterly working capital of SVA is $10.17 B
What is the all time high quarterly working capital for Sinovac Biotech?
Sinovac Biotech all-time high quarterly working capital is $12.55 B
What is Sinovac Biotech quarterly working capital year-on-year change?
Over the past year, SVA quarterly working capital has changed by -$409.57 M (-3.87%)